For instance, Illumina recently announced price cuts to $14,500 for groups of five or more genomes and to $9,500 for sequencing with ???potential direct clinical value,??? and several companies are offering genomes in the $5,000 to $10,000 range, particularly for new, large orders.2 As the next-gen sequencing market continues to expand (pdf) from traditional research applications to encompass more